Conceptio
›
Archive
›
HAL (France)
HAL (France)
open access
Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation.
Alexander Christopher Jonathan van Akkooi et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Ultrafast laser inducing bulging and nanograin refinement dynamics of polycrystalline nanospikes
#665395
A priori tests of turbulence models for compressible flows
#665396
The TPLATE complex mediates membrane bending during plant clathrin–mediated endocytosis
#665397
Enhanced Condensation Through Rotation
#665398
The inchoative failure of climate governance
#665399
Record
· ID 476014
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.